scispace - formally typeset
T

Takashi Itoh

Researcher at Takeda Pharmaceutical Company

Publications -  18
Citations -  1644

Takashi Itoh is an academic researcher from Takeda Pharmaceutical Company. The author has contributed to research in topics: Recombinant DNA & Peptide. The author has an hindex of 8, co-authored 18 publications receiving 1458 citations.

Papers
More filters
Journal ArticleDOI

A G Protein-coupled Receptor Responsive to Bile Acids

TL;DR: It is found that a novel G protein-coupled receptor, TGR5, is responsive to bile acids as a cell-surface receptor, and was abundantly expressed in monocytes/macrophages in human and rabbit.
Journal ArticleDOI

Stimulation effect of galanin-like peptide (GALP) on luteinizing hormone-releasing hormone-mediated luteinizing hormone (LH) secretion in male rats.

TL;DR: It is found that intracerebroventricular administration of GALP increased the plasma LH level but did not change the levels of other hormones, and accumulation of c-Fos protein was dramatically increased in the nuclei of LHRH-positive cells in the MPA by icv GALp administration.
Journal ArticleDOI

Galanin-like peptide stimulates food intake in the rat.

TL;DR: Results suggest that GALP is a novel orexigenic and anxiogenic peptide, as a ligand for galanin receptor subtype GalR2, and the effect of the intracerebroventricular administration of GALp induced food intakes.
Journal ArticleDOI

Renaturation of recombinant human neurotrophin-3 from inclusion bodies using a suppressor agent of aggregation.

TL;DR: In this paper, the authors applied the refolding process using the aggregation suppressor Larginine in the renaturation of neurotrophin-3, and obtained biologically active recombinant human neurotrophic protein from the inclusion bodies.
Journal ArticleDOI

Topical application of neurotrophin-3 attenuates ischemic brain injury after transient middle cerebral artery occlusion in rats.

TL;DR: Terminal deoxynucleotidyl transferase-mediated dUTP-biotin in situ nick labeling (TUNEL) staining and immunohistochemical study for caspase-3 and heat shock protein 72 (HSP72) showed that NT-3 treatment decreased the number of cells with DNA fragmentation and caspases and HSP72 expressions.